These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 398636)
21. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction. Yuen BH Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic and therapeutic modalities in women with galactorrhea. Turksoy RN; Farber M; Mitchell GW Obstet Gynecol; 1980 Sep; 56(3):323-9. PubMed ID: 6775255 [TBL] [Abstract][Full Text] [Related]
23. Galactorrhea-amenorrhea and hyperprolactinemia associated with pituitary tumors of growth-hormone- and adrenocorticotropic-hormone-secreting cells. A report of two cases. Haney AF; McCarty KS; Hammond CB J Reprod Med; 1984 Dec; 29(12):883-7. PubMed ID: 6097688 [TBL] [Abstract][Full Text] [Related]
24. [Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis]. Mychka VB; Chazova IE; Dmitriev VV; Masenko VP Ter Arkh; 2000; 72(9):10-3. PubMed ID: 11076407 [TBL] [Abstract][Full Text] [Related]
25. Prolactin secreting pituitary adenoma: a review and study of their implications for fertility in women. Fode NC; Laws ER; Abboud CF; Randall RV; Kempers RD J Neurosurg Nurs; 1980 Dec; 12(4):210-3. PubMed ID: 6906361 [No Abstract] [Full Text] [Related]
26. Syndrome of galactorrhea, amenorrhea, and obesity as possible indicators of prolactinoma: a case study approach. Shaw B; Creary L; Rao V J Natl Med Assoc; 1986 Dec; 78(12):1197-200. PubMed ID: 3806693 [TBL] [Abstract][Full Text] [Related]
28. [Hyperprolactinemia as a frequent cause of amenorrhea and galactorrhea]. Rjosk HK; Fahlbusch R; von Werder K Med Klin; 1980 Aug; 75(17):609-12. PubMed ID: 6997715 [No Abstract] [Full Text] [Related]
30. [Hyperprolactinemia in clinical practice and therapeutics]. Linquette M; Fossati P Rev Prat; 1976 Jun; 26(35):2425-34. PubMed ID: 959740 [No Abstract] [Full Text] [Related]
36. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment. Frantz AG; Kleinberg DL Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606 [TBL] [Abstract][Full Text] [Related]
38. [Prolactin-secreting microadenoma in menopausal women]. Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K Pan Afr Med J; 2017; 27():177. PubMed ID: 28904704 [TBL] [Abstract][Full Text] [Related]
39. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease. Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134 [TBL] [Abstract][Full Text] [Related]